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1.0 Introduction 
 
1.1 Basic Features of the Private Healthcare Sector 
 
Private healthcare is a healthcare system where services are paid directly for and not 
provided through insurance.  The private health care sector facilities, in various nations across the 
globe, are a part of a significant and increasing industry that poses its problems and possibilities 
for nations working in the direction of universal coverage of health. (WHO, 2016) 
Many high income nations manage the private sector through a multitude of processes to regulate 
prices, quality, levels of service, and entitlement programs for people. Crucial legal problems for 
nations with high revenues include:  the extent of interventionism needed to be adopted, options 
of systems of law and regulation, the role of different industries in controlling the provision of 
healthcare and the balance between distinct regulatory types. (WHO, 2016) Though the private 
provision is often widespread in low-income and middle-income nations, it is also relatively 
poorly controlled. Furthermore, in such nations, health system consumers face economic 
obstacles and the absence of social support. (WHO, 2016) Participants might be undereducated 
about their needs and therefore unable to assess most elements of quality and value. Hence they 
are susceptible to over-charging and maybe even quality reduction and expense escalation that 
could very well disqualify those who can afford it. 
Middle and low-income countries' core regulatory and legal challenges comprise of a need for 
more private industry details and knowledge to steer legislative choice-making, guaranteeing that 
legal and regulatory practice is well embedded with the country's strategic narration on the role of 
the private sector operating on health funding and buying agreements to guide private sector 
services towards universal health protection objectives.  There is a need for suitable legislation 
and legal frameworks to tackle efficiency, security and expense problems, constructing and 
enforcing legal and regulatory organizations as well as an assessment of the throughput for 
society to assist control the behavior of providers. (WHO, 2016) 
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2.0 European Context 
 
Across all nations, Europeans are prepared to pay a fee for personal healthcare, either to bypass 
long lines, access plastic surgery or prevent the possible danger of disease in public clinics. 
Health tourism is therefore flourishing in the European Union, where patients often travel to 
Eastern Europe for low-cost dental procedures. The especially rich Russians but also Saudi Arabs 
prefer to go to Switzerland and Germany's private doctors. Since most Europeans have access to 
public-sector service either through their compulsory social security contribution or through 
taxes, personal medical insurance remains a comparatively tiny market. Many customers prefer to 
pay single charges as and when required. (The Hindu, 2017) 
Furthermore, any employment insurance that employers pay for, makes private health insurance 
pointless. Employers are required to compensate for a certain level of healthcare for their workers 
in several European countries with a state-run national health system. Most companies are 
prepared to pay for employment healthcare for their employees because it may prevent employee 
delays to see a doctor when they become ill. (The Hindu, 2017) 
When discussing the European context, it is important to present the country with the highest 
portion of private healthcare institutions. Namely, Germany has the most developed system of 
private healthcare with the highest number of privately owned hospital beds in the European 
Union. 
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Figure 1: Hospital Beds in Private Ownership in Germany (Eurostat, 2019) 
When evaluating the information from Figure 1 about the quantity of private-owned hospital beds 
in Germany, we can immediately detect a general pattern of development in the number of beds 
over the years with two significant drops occurring over the observed period. We see a steady and 
remarkable increase in the quantity of privately owned beds from 2010 to 2012. In 2010 there 
were 200,012 private-owned beds, which increased to 201,218 by 2012, resulting in an increase 
of 1,206 over the two-year period, portraying an increase of 0.60% over the period. However, in 
2013, the amount of private-owned beds fell sharply, dropping to 198,736 beds. This strong 
decline in private hospital beds reflects a somewhat substantial 1.23 percent shrinkage compared 
to the prior year. The number of private hospital beds in Germany does indeed have a major rise 
in the following year after reaching a peak, attaining an amount of beds comparable to the 2011 
period, so the amount in 2014 corresponds to 200,206 beds, indicating a change of 0.73 percent 
from the prior year. Immediately after experiencing a recovery in the number of hospital beds in 
2014, another decrease occurs in the following year with the number of beds falling to 199,842 
beds in 2015. In 2016, the last year of the observed period, the amount of hospital beds 
encountered another significant growth reaching a final amount of 201,425 private hospital beds 
in Germany. Compared to the previous year, this ultimate development stage reflects a rise of 
0.79%. If we glance at the whole graph and the whole time period, compared to the beginning 
year of 2010 and the end year of 2016, we come to a conclusion that overall the number of 
private hospital beds in Germany has increased by 1,413 beds over the examined time period.  
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3.0 Focus on Croatia 
 
There are various options within the Croatian private healthcare sector for Croatian citizen to 
access. The service is either being paid straight away of by using the supplemental insurance.   
(HZZO, 2013) 
 
 
Figure 2: Hospital Beds in Private Ownership in Croatia (Eurostat, 2019) 
 
Figure 2 shows the complete amount of private-owned hospital beds in Croatia between 2010 and 
2016. It is evident that the number of private hospitals in Croatia has risen over the six years that 
have been published. There were only 129 private hospital beds in 2010, that amount began to 
rise in 2011, rose quickly in 2012 and peaked in 2013 at 277 privately owned hospital beds. It 
started to fluctuate over the next three years after its pinnacle and has not yet reached the highest 
quantity of beds it had in 2013 in the latest accessible year which was 2016. The numbers seem 
rather low but they are not surprising. Namely, Croatians have the ability to use public health 
services considering the high prices of privately conducted procedures so the demand for the 
number of private hospital beds is not so high. Private hospital beds are generally used for shorter 
periods of time, unlike those in public hospitals, as the processes are not as invasive, nor do they 
perform urgent surgeries that require prolonged hospital stay. 
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Figure 3: Private - sector Expenditure on Health as Proportion of Total Health Expenditure in Croatia (WHO, 2015) 
    
Figure 3 demonstrates private-sector health expenditure as a percentage of total health 
expenditure in Croatia from 1995 to 2014. The percentage of private-sector spending was 13.50% 
in 1995. It was rising over the next two years after which it's starting to drop considerably. There 
is a growth period from 1999 to 2002 achieving an ultimate peak in 2002 at 20.00%. It continued 
to fall and fluctuate until 2011, when it nearly achieved the prior peak at 19.80%. It began to 
decrease at a constant pace afterwards. The overall trend suggests fluctuations in the amount of 
private – sector expenditure as compared to the total health expenditure in Croatia. The 
expenditure has increased since 1995 but not by a tremendous amount which leads to believing 
that public healthcare still carries out the majority of health related services. 
 
 
 
 
 
13.50%
12.40%
15.50%
13.00%
12.70%
13.90%
16.70%
20.00%
17.40%
18.90%
14.00%
13.90%
13.00%
15.10%
14.30%
14.30%
19.80%
18.40%
18.20%
18.10%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
P
er
ce
n
ta
ge
 o
f 
P
ri
va
te
-s
ec
to
r 
Ex
p
en
d
it
u
re
 o
n
 H
ea
lt
h
 
as
 P
ro
p
o
rt
io
n
 o
f 
To
ta
l H
ea
lt
h
 E
xp
en
d
it
u
re
Year
Private-sector Expenditure on Health as Proportion of Total 
Health Expenditure in Croatia
7 
 
3.1 Analysis of Ten Major Special Hospitals and Polyclinics in Croatia 
 
3.1.1 Polyclinic Šlaj – Anić 
 
Polyclinic Šlaj – Anić is a Zagreb based dental polyclinic, founded in 1984. Their main fields 
include dentistry and more recently, dermatology. (Poliklinika Šlaj-Anić, 2017) 
 
 
Figure 4: Polyclinic Šlaj - Anić Assets and Equity 2009 – 2018 (Bisnode, 2019) 
 
As seen in Figure 4, Polyclinic Šlaj – Anić had initial fluctuations in both assets and equity. 
There was an overall increase in assets, it has doubled since 2009. The reason for the asset boost 
is the growth of current assets, more specifically an immense increase of cash in bank. Over the 
years, there was an increase in machinery which is a part of long term assets which makes sense 
since they present themselves as a modern dental clinic always upgrading their technology. 
Equity increased predominately due to the profit from the business year. In 2011, cash in bank 
and current assets decreased while in 2015 there is a notable surge of cash in bank. Equity peaked 
in 2015 as a result of an increase of retained earnings. Both equity and assets grew in 2018. 
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Figure 5: Polyclinic Šlaj - Anić Total Revenues 2009 – 2018 (Bisnode, 2019) 
Figure 5 denotes the total revenues of the polyclinic in the time period from 2009 until 2018. 
From 2009 until 2012, the polyclinic had a brief growth followed by a decline period but the total 
revenues stabilized and grew at a constant rate onwards. Polyclinic Šlaj Anić introduced new 
services hence experienced an increased demand over the examined years which is the main 
reason for the growth of total revenues. Since the growth period started before 2013, there is no 
correlation of Croatian’s EU entrance and the increase in revenues. 
 
 
Figure 6: Polyclinic Šlaj - Anić Net Profit 2009 – 2018  
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Net profit is used to assess company’s performance and indicate its profitability. Figure 6 
illustrates net profits of each year from 2009 to 2018 which is decent amount of time for 
observations. Looking at the graph, it is evident that for all ten years, Polyclinic Šlaj – Anić had 
no net loss. In fact, their net profit increased. However, some fluctuations occurred in the period 
before 2013, the situation changes and the polyclinic experiences growth onward. 
 
Year Current ratio Return on assets 
2009 0.88  ≤ 2 43.78% 
2010 3.31 ≥ 2 66.85% 
2011 7.32 ≥ 2 67.42% 
2012 2.48 ≥ 2 48.75% 
2013 3.06 ≥ 2 52.37% 
2014 2.30 ≥ 2 50.95% 
2015 3.22 ≥ 2 47.17% 
2016 1.49 ≤ 2 59.06% 
2017 2.93 ≥ 2 64.43% 
2018 3.54 ≥ 2 61.76% 
Table 1: Polyclinic Šlaj – Anić Current Ratio and Return on Assets (Bisnode, 2019) 
 
Current ratio over 2 means that current assets are twice as large as current liabilities. Current ratio 
less than 2 indicates that a company is not able to cover its short term liabilities and financial 
obligations lasting less than one year.  
Table 1 shows current ratio and return on assets of Polyclinic Šlaj – Anić from 2009 to 2018. It is 
apparent that the company was unable to cover its short-term obligations in 2009, but changes 
were made in the following year. In general, the current ratio exceeds 2 in each year except in 
2016, when it is equivalent to 1.49, which suggests a rather favorable financial health. 
Return on assets is a financial ratio that indicates a business's proportion of profit relative to its 
general resources. ROA is usually acceptable, exceeding 5 percent. ROA was very high in every 
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year which represents great business efficiency - the higher the return on assets, the greater the 
management. 
 
3.1.2 Polyclinic Aviva 
 
Polyclinic Aviva was founded in 1997 as a successor to the Nemetova Polyclinic. They 
specialize in Magnetic Resonance Imaging, ultrasounds, gastroenterology, gynecology, 
cardiology, psychiatry and neurology. (Poliklinika Aviva, 2019) 
 
 
Figure 7: Polyclinic Aviva Assets and Equity 2009 – 2018 (Bisnode, 2019) 
 
Figure 7 shows how, over the ten years studied, the total assets of Polyclinic Aviva have 
declined. Assets were the highest in 2009 and started to slightly reduce in 2010. This event was 
followed by a steep downfall with the lowest point being in 2012. Assets have since started to 
recover but ended up reducing eventually. The intriguing aspect is that the reason for the decrease 
in assets is the decrease in machinery quantity which could indicate lack of investment in 
technology. Significant equity changes occurred from 2009 to 2012 as there was a large rise in 
retained earnings in 2012.  
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Figure 8: Polyclinic Aviva Total Revenues 2009 – 2018 (Bisnode, 2019) 
 
Figure 8 demonstrates the total revenues of Polyclinic Aviva during the interval under review. 
Polyclinic Aviva's total revenues grew from 2009 to 2018 owing to a number of variables. 
Namely, there was a massive rise in operating revenues of the polyclinic. On the other side, there 
was a drop in interest and financial expenses. 
 
 
Figure 9: Polyclinic Aviva Net Loss 2009 – 2018 (Bisnode, 2019) 
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Figure 9 denotes the net loss experienced by Polyclinic Aviva from 2009 to 2018. Unlike 
Polyclinic Šlaj – Anić that had net profit in all years, Polyclinic Aviva has astonishing levels of 
net loss. In 2002 they already had over one-million-euro net loss, but there was an even greater 
plummet in 2011 reaching almost 2.5-million-euro loss. Those numbers have improved over the 
years but the polyclinic is still not operating profitably.  
 
Year Current Ratio Return on assets 
2009 0.963485902 ≤ 2 -35.09% 
2010 1.072096642 ≤ 2 -50.90% 
2011 0.76511674 ≤ 2 -99.72% 
2012 0.274466651 ≤ 2 -84.04% 
2013 0.154047528 ≤ 2 -61.39% 
2014 0.121206023 ≤ 2 -36.34% 
2015 0.136037933 ≤ 2 -42.18% 
2016 0.144078492 ≤ 2 -24.58% 
2017 0.187689198 ≤ 2 -10.21% 
2018 0.185564018 ≤ 2 -9.53% 
Table 2: Polyclinic Aviva Current Ratio and Return on Assets (Bisnode, 2019) 
 
The current ratio of Polyclinic Aviva is constantly exceptionally small. It has never reached the 
minimum threshold in the ten years it was examined. This is not at all unexpected given that in 
all these years they have had net loss. 
Table 2 also depicts their return on assets. Not only do they fail to satisfy the 5 percent minimum 
obligation, their ROA is negative at all times. Company is neither liquid nor profitable, there is 
poor financial health and their company is not effective. 
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3.1.3 Special hospital Arithera 
 
Special hospital Arithera was founded in 2003 in Zagreb. They specialize in general surgery, 
internal medicine, physical therapy, orthopedics, rehabilitation, dermatology and venereology. 
(Specijalna bolnica Arithera, 2013) 
 
 
Figure 10: Special Hospital Arithera Assets and Equity 2009 – 2018 (Bisnode, 2019) 
 
Figure 10 presents the polyclinic’s assets and equity from 2009 to 2018. Special hospital Arithera 
encountered periods of rapid assets growth and plateau phases while almost stagnating from 2009 
to 2011. This is because there have been spikes in current assets over the years of development. 
On the other hand, due to retained earnings, equity grew at an exceptionally slow pace. 
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Figure 11: Special Hospital Arithera Total Revenues 2009 – 2018 (Bisnode, 2019) 
 
Figure 11 shows how Special hospital Arithera’s total revenues fluctuated from 2009 until 2014. 
Rapid development took place in 2014, and it was still active in 2018. Growth occurred 
subsequent to a rise in financial income and operating income, and sales increased significantly 
from 2016 to 2018. It is essential to note that operating expenses have also increased, but not so 
rapidly. 
 
 
Figure 12: Special Hospital Arithera Net Profit 2009 – 2018 (Bisnode, 2019) 
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Figure 12 displays the net profit and loss that occurred within Special hospital Arithera’s 
business. In 2009, they encountered low levels of net profit which, with minimal fluctuations, 
remained at the same level until 2015.  From 2014 to 2015, special hospital underwent a major 
net loss followed by the largest net profit recorded within just one year. The net profit has been 
falling ever since but is still positive.  
 
Year Current ratio Return on assets 
2009 0.50 ≤ 2 0.62% 
2010 0.73 ≤ 2 1.05% 
2011 1.09 ≤ 2 1.09% 
2012 0.52 ≤ 2 0.44% 
2013 0.59 ≤ 2 0.49% 
2014 1.45 ≤ 2 0.38% 
2015 0.77 ≤ 2 0.39% 
2016 0.93 ≤ 2 0.93% 
2017 0.80 ≤ 2 0.87% 
2018 0.78 ≤ 2 0.21% 
Table 3: Special Hospital Arithera Current Ratio and Return on Assets (Bisnode, 2019) 
 
Table 3 demonstrates Special hospital Arithera’s current ratio and return on assets levels from 
2009 to 2018. Current ratio was unsatisfactory in all years as it was below 2. Comparing 2018 to 
2009, it is visible that current ratio has improved but seeing that in 2014 the hospital experienced 
a ratio of 1.45, it is not looking as positive as it could. Their financial health and liquidity do not 
paint a positive picture of the company.  
Return on assets is positive, but it does not equal 5% in any of the years. In most periods, it is 
under 1% and only exceeds it in 2010 and 2011. ROA indicates that Special hospital Arithera 
does not have good business efficiency and prosperity. 
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3.1.4 Special Hospital Akromion 
 
Special hospital Akromion was founded on April 11th 2008. They operate on two locations, in 
Zagreb and in Krapinske Toplice. They do examinations in their Zagreb clinic and surgeries in 
Krapinske Toplice hospital. They specialize in orthopedics and traumatology.  Special hospital 
Akromion is the largest private orthopedic hospital in Croatia and have a status of E – hospital 
meaning that the hospital is completely computerized. (Specijalna bolnica Akromion, 2017) 
 
 
Figure 13: Special Hospital Akromion Assets and Equity 2009 – 2018 (Bisnode, 2019) 
 
Special hospital Akromion had an initial growth of assets caused by increase of cash in bank. The 
assets reached their peak in 2012 and went on to decline due to decrease of cash in bank. In 2013 
their short term financial assets become zero and did not change. Equity remained stable until a 
small growth period from 2014 and the first half of 2015. However, an intense plummet, 
triggered exclusively by accumulated deficit, characterizes the second half of 2015. Accumulated 
deficit rates enhanced and continued to rise in the second half of 2016. 
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Figure 14: Special Hospital Akromion Total revenues 2009 – 2018 (Bisnode, 2019) 
 
Figure 14 shows Special hospital Akromion’s total revenues from 2009 to 2018. The hospital’s 
total revenues constantly oscillate over the years because operating income changes due to 
fluctuating sales.  
 
 
Figure 15: Special Hospital Akromion Net Profit or Loss 2009 – 2018 (Bisnode, 2019) 
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Figure 15 presents Special hospital Akromion’s net profit and loss over ten years observed. 2009 
was rather an unfavorable period for the hospital because they suffered net loss of almost four 
hundred thousand euros. It seems as if things picked up for them due to the rise in profit over the 
next five years but the company encountered loss again. They had a rather quick rise of profits 
within a year and net profit still keeps increasing.  
 
Year Current ratio Return on assets 
2009 0.39 ≤ 2 -46.46% 
2010 0.42 ≤ 2 -23.53% 
2011 0.38 ≤ 2 -6.48% 
2012 0.49 ≤ 2 3.11% 
2013 0.39 ≤ 2 6.29% 
2014 0.19 ≤ 2 10.12% 
2015 0.12 ≤ 2 -35.69% 
2016 0.21 ≤ 2 12.40% 
2017 0.22 ≤ 2 39.16% 
2018 0.31 ≤ 2 54.26% 
Table 4: Special Hospital Akromion Current Ratio and Return on Assets (Bisnode, 2019) 
 
Table 4 represents the current ratio and return on assets of Special hospital Akromion. Their 
current ratio is lower than two at all times and has even lowered over the ten years. This trend is 
not good for the company’s liquidity and their financial health. 
Return on assets is low in the first three years but it recovers in 2013. In the latter three years 
their ROA increases significantly. This shows that the hospital has improved their business 
efficiency.  
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3.1.5 Special Hospital Svjetlost 
 
Special hospital Svjetlost is a leading ophthalmology hospital founded in January 2008.  They 
operate in several locations: Zagreb, Split, Bosnia and Herzegovina in Sarajevo and Banja Luka, 
Novi Sad in Serbia and Budva in Montenegro. (Specijana bolnica Svjetlost, 2015) 
 
 
Figure 16: Special Hospital Svjetlost Assets and Equity 2009 – 2018 (Bisnode, 2019) 
 
Figure 16 shows the development era of Svjetlost Special Hospital which spanned from 2009 to 
2014 with the peak of assets in 2014. Graph shows some changes, but general development 
exists. Growth occurred due to an increase in long-term assets, short-term assets and financial 
assets. There was a drop in 2017 due to financial assets suddenly being equal to zero which 
lowered the total assets line. Equity was rising from 2009 to 2010 when it started gradually 
decreasing. Those changes were not of a big scope and even turned into growth with a 2016 peak. 
The peak was caused by the current year profits. Equity plummeted in 2017 as the profit 
decreased. 
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Figure 17: Special Hospital Svjetlost Total Revenues 2009 – 2018 (Bisnode, 2019) 
 
Figure 17 represents Special hospital Svjetlost’s total revenues over ten years. In the years 
mentioned, even with some minor changes, total revenues grew. Growth was due to increased 
operating income, higher revenues, and higher financial income. 
 
 
Figure 18:Special Hospital Svjetlost Net Profit 2009 – 2018 (Bisnode, 2019) 
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By analyzing figure 18, it is clear that Special hospital Svjetlost’s net profit has grown over the 
years. In 2009 their profit was just over 100,000 euros and has climbed in the following years 
with a slight decline in 2011. Net profit reached a peak in 2016 after which it plummeted. It 
started recovering and is currently on a growth path.  
 
Year Current ratio Return on assets 
2009 2.92 ≥ 2 28.22% 
2010 1.07 ≤ 2 42.95% 
2011 0.39 ≤ 2 27.87% 
2012 0.91 ≤ 2 29.64% 
2013 0.74 ≤ 2 28.03% 
2014 0.55 ≤ 2 28.35% 
2015 0.48 ≤ 2 34.07% 
2016 1.24 ≤ 2 55.68% 
2017 0.72 ≤ 2 22.11% 
2018 1.09 ≤ 2 37.04% 
Table 5: Special Hospital Svjetlost Current Ratio and Return on Assets (Bisnode, 2019) 
 
Table 5 shows Special hospital Svjetlost’s current ratio and return on assets. In 2002, current 
ratio was 2.92 which is above 2 and indicates good liquidity and financial health. After that 
period, current ratio fell and fluctuated but never reached the initial value. That is not a good sign 
regarding the company’s liquidity. Special hospital’s return on asset, on the other hand, met the 
satisfactory amount as they are above 5% at all times. This proves business efficiency within the 
company and mindfulness when using assets to generate earnings.  
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3.1.6 Polyclinic Bagatin 
 
Polyclinic Bagatin was founded in 1995 as the founder’s private practice for maxillofacial 
surgery. The polyclinic offers over 250 services on three locations within Zagreb and Split. Their 
focus is plastic surgery and dermatology. (Poliklinika Bagatin, 2014) 
 
 
Figure 19: Polyclinic Bagatin Assets and Equity 2009 – 2018 (Bisnode, 2019)  
 
Figure 19 displays Polyclinic Bagatin’s assets and equity from 2009 until 2018. In the early 
years, both assets and equity started low and slowly increased until 2013. In 2013, the incline of 
assets becomes steeper. This is due to an increase in tangible assets, receivables, inventories and 
short term financial assets. Equity rose for the entire period at a steady pace. The rise was a result 
of increased retained earnings, current year profit as well as subscribed capital. 
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Figure 20:Polyclinic Bagatin Total Revenues 2009 – 2018 (Bisnode, 2019) 
 
Figure 20 presents Policlinic Bagatin’s total revenues. Over the years examined, the total 
revenues of Polyclinic Bagatin witnessed a fast rise. The increase is linked to the rise of sales as 
tangible assets also expanded as a consequence of improvements in equipment. 
 
 
Figure 21:Polyclinic Bagatin Net Profit 2009 – 2018 (Bisnode, 2019) 
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In Figure 21, the graph of the net profit of Polyclinic Bagatin shows stagnation in 2009 and 2010 
followed by a rapid phase of growth and maturity completed with a fall in 2015. Net profit picks 
up in 2015 just to begin to decline in 2016. The situation has not changed yet. The declining net 
profit of the company is an indication of company’s low profitability.  
 
Year Current ratio Return on assets 
2009 0.06 ≤ 2 49.45% 
2010 0.21 ≤ 2 0.86% 
2011 1.05 ≤ 2 30.69% 
2012 1.48 ≤ 2 27.22% 
2013 1.95 ≤ 2 49.45% 
2014 1.76 ≤ 2 10.23% 
2015 0.84 ≤ 2 5.53% 
2016 0.75 ≤ 2 5.83% 
2017 0.76 ≤ 2 49.45% 
2018 1.25 ≤ 2 2.59% 
Table 6: Polyclinic Medikol Current Ratio and Return on Assets (Bisnode, 2019) 
 
Table 6 shows how the current ratio and return on assets change over ten years. Current ratio 
started very low at only 0.06 but started increasing afterwards. 2013 was quite promising for the 
polyclinic’s current ratio hence their liquidity. It started to fall just a year later and hasn't 
recovered. Due to the low current ratio, their liquidity and financial health do not promise a 
positive future impact. Return on assets started out high, however, in this case both net profit and 
total assets were extremely low so the high percentage does not reflect the real situation. There is 
a significant fall in 2010 because net profit stayed at the same low level while total assets 
increased dramatically. The percentages change a lot over the years. There is a drastic fall in 
2015, 2016 and 2018 and the reason behind this is an immense increase in total assets and a little 
to no increase in net profit. For the most part, the polyclinic still has an acceptable business 
efficiency.  
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3.1.7 Polyclinic Medikol 
 
Polyclinic Medikol was established in 2000 as a solely radiology private institution. They are 
currently located in seven locations in five Croatian cities: Zagreb, Rijeka, Čakovec, Split and 
Osijek. The polyclinic offers services in the fields of neurology, radiology, dermatology, nuclear 
medicine, internal medicine, gynecology, ophthalmology, urology, podiatry, physical therapy and 
rehabilitation.  (Poliklinika Medikol, 2013) 
 
 
Figure 22: Polyclinic Medikol Assets and Equity 2009 – 2018 (Bisnode, 2019) 
 
In Figure 22, the trend of asset and equity movement through the years can be observed. In the 
2009 and 2010, assets continued to expand and then began to drop in the second half of 2012. 
There was an unexpected plummet in mid-2016 as a consequence of a drop in tangible assets and 
current assets, short term financial assets and receivables. Equity also declined due to 
diminishing revaluation reserves and current year profit.  
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Figure 23: Polyclinic Medikol Total Revenues 2009 – 2018 (Bisnode, 2019) 
 
Figure 23 portrays Polyclinic Medikol’s total revenues. In the first three years there was an 
almost linear increase with a pinnacle in 2011. There was a downturn from the mid-2011 until 
2014. The small rise did not create the conditions like they were in 2011, in reality another 
decrease occurred. The major downsizing of total revenues happened because there was a decline 
is the dropping of the item other business revenues. 
 
 
Figure 24:Polyclinic Medikol Net Profit or Loss 2009 – 2018 (Bisnode, 2019) 
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Polyclinic Medikol’s net profit and loss is seen in Figure 24. 2010 was the most profitable year 
for them with profits reaching 3.5 million euros. After the success came a dramatic fall, reaching 
loss in 2014. They became profitable again on 2015 but their profit is not significant considering 
their size.  
 
Year Current ratio Return on assets 
2009 0.30 ≤ 2 10.94% 
2010 0.38 ≤ 2 10.08% 
2011 0.33 ≤ 2 2.81% 
2012 0.35 ≤ 2 0.19% 
2013 0.13 ≤ 2 1.17% 
2014 0.63 ≤ 2 -2.37% 
2015 0.76 ≤ 2 1.72% 
2016 0.74 ≤ 2 1.61% 
2017 0.60 ≤ 2 31.95% 
2018 0.67 ≤ 2 40.82% 
Table 7: Polyclinic Medikol Current Ratio and Return on Assets (Bisnode, 2019) 
 
Table 7 exhibits current ratio and return on assets of Polyclinic Medikol. Based on their current 
ratio values, the business is not liquid. Such small values portray financial health issues in the 
foreseeable future. Return on investments was fair in 2009 and 2010 but began to collapse in 
2011. Looking back at Figure 24 and observing net profit in all years with poor asset return it is 
clear that the highest one was in 2014 when the business suffered net loss. In 2017 and 2018, 
percentage increase remarkably due to a rise in net profit.  
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3.1.8 Special Hospital Agram 
 
Special hospital Agram was established in 1995. Their specialties include gynecology, internal 
medicine, radiology and surgery. They opened hospitals in seven Croatian cities: Zagreb, Split, 
Varaždin, Slavonski Brod, Zadar, Rijeka and Osijek. (Specijalna bolnica Agram, 2018) 
 
 
 
Figure 25: Special Hospital Agram Assets and Equity 2009 – 2018 (Bisnode, 2019) 
 
Figure 25 displays Special hospital Agram’s assets and equity changing over ten years.  Over the 
years, the assets of Special Hospital Agram fluctuated and peaked in 2011, but subsequently 
dropped. There were fluctuations corresponding to machinery oscillations, declines in 
receivables, growth of cash in bank. Not much of a transition has occurred overall. Equity 
remained stable until 2013 when a decline occurred as a result of the current year loss. 
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Figure 26: Special Hospital Agram Total Revenues 2009 – 2018 (Bisnode, 2019) 
 
Special hospital Agram’s total revenues are shown in Figure 26. 2009 had the highest amount of 
total revenues. Over the years, revenues fluctuated somewhat even had a drop in 2013 but have 
since been growing steadily.  
 
 
Figure 27: Special Hospital Agram Net Profit or Loss 2009 – 2018 (Bisnode, 2019) 
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Net profit and loss of Special hospital Agram can be seen in Figure 27. In 2009, net profit was 
present but was rather low. The trend continued until 2012 when profit suddenly dropped and 
became a loss. Net loss became net profit in 2014 and it seems as if the company was on the right 
track, however, profits first reached a plateau then took a downward turn. At this point, it is not 
clear if the company will experience loss once again in 2019.  
 
Year Current ratio Return on assets 
2009 1.05 ≤ 2 1.93% 
2010 0.93 ≤ 2 1.81% 
2011 1.29 ≤ 2 0.33% 
2012 2.00 ≥ 2 1.19% 
2013 1.13 ≤ 2 -72.43% 
2014 0.80 ≤ 2 -59.19% 
2015 1.80 ≤ 2 50.08% 
2016 0.75 ≤ 2 52.00% 
2017 1.27 ≤ 2 52.30% 
2018 1.23 ≤ 2 9.81% 
Table 8: Special Hospital Agram Current Ratio and Return on Assets (Bisnode, 2019) 
 
Table 8 introduces Special hospital Agram’s current ratio and return on assets. Current ratio 
lower that 2 in all years except for 2012. It shows that the special hospital is not tremendously 
liquid and it is not in the best financial health. Return on assets was not acceptable in the first six 
years, it even became negative in 2013 and 2014. The cause of the drop was net loss that 
occurred at that time. 2015 was a real turning point for the company when return on assets 
becomes over fifty percent. Values fell later on but they are still tolerable.   
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3.1.9 Polyclinic Identalia 
 
Polyclinic Identalia is a dental polyclinic located in Zagreb. They were founded in 2012. They 
pride themselves with owning the latest technologies. (Poliklinika Identalia, 2013) 
 
 
Figure 28: Polyclinic Identalia Assets and Equity 2012 – 2018 (Bisnode, 2019) 
 
Figure 28 represents assets and liabilities movements from 2012 to 2018. There has been a 
constant rise in their assets since then. Current and non-current assets contribute similarly to 
development. Loans began to be part of their long-term assets in 2016. The equity line is 
increasing and the reason behind the rise is the growth of retained earnings and current year 
profits.  
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Figure 29: Polyclinic Identalia Total Revenues 2012 – 2018 (Bisnode, 2019) 
 
Polyclinic Identalia’s total revenues from 2012 to 2018 are explained in Figure 29. As a 
consequence of operating sales, total revenues rose instantly after the foundation. In 2016, the 
company had a tiny fall, accompanied by an era of development. The growth is still present but  
moving at a slower pace. 
 
 
Figure 30: Polyclinic Identalia Net Profit 2012 – 2018 (Bisnode, 2019) 
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Figure 30 presents Polyclinic Identalia’s net profit. The polyclinic’s net profits grew at a rapid 
pace from 2012 until 2015 when they reached their highest point. There was a plummet in the 
following year but net profit recovered afterwards.  
 
Year Current ratio 
Return on assets 
 
2012 0.18 ≤ 2 3.13% 
2013 1.28 ≤ 2 46.39% 
2014 3.23 ≥ 2 65.67% 
2015 6.01 ≥ 2 52.87% 
2016 2.32 ≥ 2 14.99% 
2017 3.26 ≥ 2 10.30% 
2018 1.74 ≤ 2 10.97% 
Table 9: Polyclinic Identalia Current Ratio and Return on Assets (Bisnode, 2019) 
 
Polyclinic Identalia’s current ratio and return on assets are visible in Table 9. For the first two 
years, the current ratio has been below two. In 2014, their liquidity improved with current ratio 
growing over three. The trend continued until 2018 when it declined but it is not a terrible sign 
looking at previous years. Return on assets was under 5% only in 2012. Those number became 
higher which proves business efficiency.  
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3.1.10 Polyclinic Rident 
 
Polyclinic Rident is Croatian largest dental polyclinic. They were established in 2003 in Rijeka. 
They currently have two locations in cities within Croatian region Istria: Rijeka and Poreč. In 
2018, the polyclinic had the most employees out of all ten polyclinics and hospitals examined in 
this paper. (Rident, 2019) 
 
 
Figure 31: Polyclinic Rident Assets and Equity 2009 – 2018 (Bisnode, 2019) 
 
Figure 31 defines Polyclinics Rident's total assets and equity progress from 2009 to 2018. Total 
assets rose due to an increase in intangible assets. Namely, Polyclinic Rident has continued to 
invest in patents and licenses over the years, increasing short and long-term financial assets as a 
result of lending and investing in securities. Their cash in bank and receivables increased as well.  
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Figure 32: Polyclinic Rident Total revenues 2009 – 2018 (Bisnode, 2019) 
 
Figure 32 exhibits total revenues of Polyclinic Rident in the time span of ten years. Total 
revenues have increased as a result of an increase in operating income. Every year, Polyclinic 
Rident welcomes more and more company traffic which has had a major impact on their 
revenues. 
 
 
Figure 33: Polyclinic Rident Net Profit 2009 – 2018 (Bisnode, 2019) 
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Polyclinic Rident’s net profit can be seen in Figure 33. Net profit was high in 2009, it fluctuated 
over the years but it has been on an upturn since 2016. Those high numbers will be important in 
Table 10, looking at the company’s return on assets.  
 
Year Current ratio Return on assets 
2009 5.11 ≥ 2 54.28% 
2010 7.34 ≥ 2 45.32% 
2011 7.40 ≥ 2 42.63% 
2012 10.03 ≥ 2 42.72% 
2013 3.36 ≥ 2 25.46% 
2014 3.09 ≥ 2 24.75% 
2015 3.51 ≥ 2 28.47% 
2016 2.29 ≥ 2 19.26% 
2017 2.00 ≥ 2 25.10% 
2018 4.28 ≥ 2 32.40% 
Table 10: Polyclinic Rident Current Ratio and Return on Assets (Bisnode, 2019) 
 
Table 10 shows Polyclinic Ridents’s current ratio and return on assets. Ever since 2009, their 
current ratio was excellent, exceeding two in each year. This means that the company is very 
liquid and in great financial health. Return on assets is good in all years proving that the 
polyclinic is operating efficiently. 
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4.0 Future of the Private Healthcare Sector 
 
Croatian private healthcare sector has an immense potential to grow since demand for privately 
offered services keeps increasing. The advantage of private healthcare sector compared to the 
public healthcare sector is that consumers feel like they get services of higher quality when they 
visit a private healthcare institution. Besides that, patients that wish to get examined immediately, 
instead of waiting for months, can do it with ease.  
The following two tables prove the point made about the potential for growth viewed through 
salaries and the number of employees for each of the observed special hospitals and polyclinics 
from 2014 to 2018.  
Table 11: Average Net Salary (EUR) 2014-2018 (Poslovna Hrvatska, 2019) 
 
Average Net Salary (EUR) 2014-2018 
 2014 2015 2016 2017 2018 
Polyclinic Šlaj - Anić 719.00 730.00 745.00 741.00 826.00 
Polyclinic Aviva 1,470.00 1,529.00 1,552.00 1,551.00 1,665.00 
Special Hospital Arithera 556.00 542.00 629.00 747.00 810.00 
Special Hospital 
Akromion 
1,183.00 1,160.00 1,109.00 1,142.00 1,148.00 
Special Hospital Svjetlost 1,008.00 958.00 1,048.00 1,245.00 1,361.00 
Polyclinic Bagatin 617.00 599.00 712.00 837.00 802.00 
Polyclinic Medikol 861.00 894.00 914.00 970.00 1,017.00 
Special Hospital Agram 1,131.00 1,141.00 1,224.00 1,207.00 1,248.00 
Polyclinic Identalia 534.00 647.00 741.00 781.00 829.00 
Polyclinic Rident 838.00 
829.00 
 
879.00 
 
994.00 
 
1,075.00 
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Table 11 represents the average net salary (EUR) recorded from 2014 until 2018. Wages in 
almost all ten polyclinics and special hospitals have risen considerably since 2014 up until 2018. 
Unfortunately, information is not accessible from before Croatia joined the European Union, so it 
is not feasible to say whether the entry had an impact on wage rises, but it provides a good 
indication of the favorable future. 
Virtually all institutions increased their wages except for Special Hospital Akromion whose 
wages decreased. If we hold 2014 as the base year, the salary shifts are as follows: Akromion 
Special Hospital was the only one to suffer a drop in salaries (by 2.95%), Special Hospital Agram 
increased their wages by 10.34%, Polyclinic Aviva by 13.26%, Polyclinic Šlaj - Anić increased 
by 14.88%, Polyclinic Medikol by 18.12%, Polyclinic Rident by 28.28%, Polyclinic Bagatin by 
29.98%, Special Hospital Svjetlost by 35.02%, Special Hospital Arithera by 45.68% and lastly, 
the greatest increase in wages occurred in Polyclinic Identalia by a an impressive 55,24%. Wages 
can continue to grow because more people use their services 
 Number of Employees 
 2014 2015 2016 2017 2018 
Polyclinic Šlaj - Anić 26 29 34 40 41 
Polyclinic Aviva 68 69 62 66 64 
Special Hospital Arithera 23 58 52 54 56 
Special Hospital Akromion 50 50 50 49 58 
Special Hospital Svjetlost 63 62 56 59 64 
Polyclinic Bagatin 22 46 53 66 87 
Polyclinic Medikol 167 171 175 172 176 
Special Hospital Agram 149 156 157 163 167 
Polyclinic Identalia 88 77 74 82 92 
Polyclinic Rident 150 177 178 178 186 
Table 12: Number of Employees (Bisnode, 2019) 
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Table 12 discusses the number of employees in each of the ten polyclinics and special hospitals 
that have been examined. Everyone, except for Polyclinic Aviva, eventually increased the amount 
of employees by 2018. This is an indication that business in the private sector is on the rise. 
Demand is increasing, so there is a need to increase the number of personnel.  
 
5.0 Conclusion 
 
In brief, the expectations for the private healthcare sector in Croatia, after entering European 
Union, were that the private sector would operate more profitably and experience growth because 
of the ease of access for foreigners to visit Croatian polyclinics. In spite of that, by observing the 
sample, it can be concluded, that there was not much of the change in the growth patterns. The 
possible reason could be that Croatian government does not actively support and encourage the 
growth of health tourism.  
It is difficult to assess the macro view of the private healthcare industry because, as seen by 
observing a sample of ten special hospitals and polyclinics, there is no constant increase or 
decrease across all factors analyzed. It is necessary to conduct a microeconomic analysis of each 
institution separately and assess their individual situation in order to discover the cause of incline 
and decline of profits in the observed period. Genially speaking, demand for services in the 
private sector grew but that could be because of distrust in the public health care sector and 
affordable prices. Croatia is following a world trend of increasing the number of private health 
care institutions but some do not operate very profitably.  
 
In conclusion, entrance of Croatia in the European Union did not have a great impact on the 
private healthcare sector. It certainly helped to create the potential to assist Croatian private 
institutions in promoting their services to foreigners but only a few seized that opportunity.  
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